Manoj Kumar, Director, DSM to Speak at Biobased Chemicals Conference, Sep 13-14 in San Francisco

Top Quote Manoj Kumar, Director, DSM to Speak at Biobased Chemicals Conference, Sep 13-14 in San Francisco. End Quote
  • San Diego, CA (1888PressRelease) July 09, 2012 - The panel discussion on "Securing Funding & Strategic Partnerships" will allow an open interaction to discuss the pros and cons of Venture Capital vs. Corporate Investors as well as when to initiate and how to select strategic partnerships. Key success factors for raising financing, what investors are looking for, and trends in favorable deal structures to off-set / discharge risk will also be discussed. Take part in this discussion and learn what is going behind the headlines of the deal terms.

    Other distinguished panelists include Erik Rutten, Senior Investment Manager at DSM Venturing; Kevin Gray, Vice President, Biobased Chemicals at Chemtex; Randy Cortright, Executive Vice President, Founder & Chief Technology Officer of Virent.

    GTC's 3rd Biobased Chemicalse Commercialization & Partnering Conference will bring together the top companies and experts together to examine new supply chain developments and business models being adopted for bringing biobased chemicals products to market. The session topics include novel chemical production platforms, advantageous feedstock, end user applications, securing funding & strategic partnerships, trends & challenges in commercial scale up.

    Presenting will be Top Executive Speakers from the following companies: Amyris, BASF, Bayer MaterialScience LLC., CBiRC, Ceres, Inc., Chemtex, Codexis, DSM, DSM Venturing, Flagship Ventures, Genomatica, Gevo, LanzaTech, Ls 9, Lux Research, Myriant Corporation, OPX Biotechnologies, Proterro, Segetis, Solazyme, The Dow Chemical Company, USDA, Agricultural Research Service, Western Regional Research Center, USDA, Environmental Managment Division (EMD), Verdezyne, Virdia, Virent, ZeaChem and many more!

    To view the Program Agenda Click Here. For more information, please visit

  • FB Icon Twitter Icon In-Icon
Contact Information